Therapeutic Target
Because of its involvement in autoimmune conditions, IL-17 inhibitors are being investigated as possible treatments, e.g. vidofludimus in phase IIB for rheumatoid arthritis, psoriasis and inflammatory bowel disease. As of early 2012, clinical trials of IL-17 antibodies against psoriasis have shown extremely promising results in Phase II. IL-17 has also been implicated in multiple sclerosis. The anti-IL-23 antibody ustekinumab can be used to effectively treat psoriasis by reducing IL-17.
Read more about this topic: Interleukin 17
Famous quotes containing the words therapeutic and/or target:
“As a science of the unconscious it is a therapeutic method, in the grand style, a method overarching the individual case. Call this, if you choose, a poet’s utopia.”
—Thomas Mann (1875–1955)
“But this we know, the obstacle that checked
And tripped the body, shot the spirit on
Further than target ever showed or shone.”
—Robert Frost (1874–1963)